Purchase Order N3239815P0340
Award Date 4/29/15
Potential Completion Date 2/29/16
Potential Value $150K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $5,699,486.00 federal contract award from the Bureau of Medicine and Surgery, a defense agency, to Sanaria Inc., a for-profit, veteran-owned business and manufacturer. The contract is for research and development services, with a performance period ending on October 31, 2018. Sanaria Inc. has provided services such as asexual malaria blood culture, clinical trial services for an investigational malaria vaccine, and research and development of P. falciparum sporozoite vaccines. This...
- This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
- This is a federal research and development contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a biotechnology company, for the development of a multi-strain malaria vaccine. The contract has a total potential value of $2,799,216.00 and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation and is set to be completed by July 18, 2019. Sanaria Inc. has previously provided services to support malaria...
- This is a $2,399,997.00 federal contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a for-profit, veteran-owned biotechnology company that manufactures goods. The contract is for research and development services, including providing asexual malaria blood culture service and conducting phase III clinical trials for an investigational malaria vaccine involving Plasmodium falciparum sporozoites. Sanaria Inc. has also received grants from the National...
- This is a $3,397,349.60 fixed-price level of effort contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Sanaria Inc., a veteran-owned biotechnology company, for a Phase III clinical trial of an investigational malaria vaccine. The contract is for the production and delivery of Plasmodium falciparum sporozoites, the parasite that causes malaria, to support the clinical trial. Sanaria Inc. has previously provided services to the National Institutes of Health and...
- <p>This is a $148,402.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sanaria, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for "Delivery System for Cryopreserved Eukaryotic Cell Vaccines" research and development work, with a completion date of January 10, 2019. The contract was set aside for small businesses.</p>
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $89,054.88 firm fixed price purchase order to Sanaria Inc. to provide asexual malaria blood culture service. The contract calls for monthly delivery of Plasmodium falciparum asexual parasites at over 90% ring stage, complete culture medium, and human blood for use in the National Center for Translational Sciences' malaria viability assays to support...
- This federal contract award was made by the Bureau of Administration, a civilian agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods. The $22,258.50 firm fixed price purchase order is for the provision of medical supplies, with a completion date of July 28, 2024. No set-aside was used for this award. Sanofi Pasteur Inc. is an established federal contractor, holding several Indefinite Delivery Vehicles (IDVs) to provide pharmaceutical products and vaccines to various...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Sanofi Pasteur Biologics, LLC, a foreign-owned for-profit organization. The contract is for the development and testing of a modified vaccinia Ankara (MVA) vaccine, with a ceiling value of $12,667,339.96. The contract is a definitive, cost-plus-fixed-fee contract type, with a final completion date of January 8, 2007. The...
- This firm fixed-price purchase order contract, valued at $75,848.00, was awarded by the Bureau of Medicine and Surgery, a defense agency, to the La Jolla Institute for Immunology, a non-profit research institute. The contract has two main tasks: 1) Predicting MHC class I and II epitopes for 400 prioritized Plasmodium falciparum proteins based on HLA data from 28 research subjects, and 2) Predicting MHC class I and II epitopes within the three NAVOX vaccine antigens (CSP, AMA1, and TRAP) based on...